Coronavirus antiviral resistance database (Robert Shafer)

Shafer’s team has created an online database of compounds with proven or potential anti-COVID-19 activity. The compounds include targeted anti-virals, repurposed drugs, investigational agents and other compounds that inhibit virus replication. The data come from published biochemical, cellular, small animal, nonhuman primate and human clinical studies. The goal of the database is to provide a uniform way to report experimental results, enabling comparisons between different compounds and allowing prioritization for further development. Stanford Office of Technology Licensing info@otlmail.stanford.edu. 650-723-0651